236 related articles for article (PubMed ID: 8152532)
21. Serotonin-antagonist effects of 1-(1-naphthyl)piperazine on operant behavior of squirrel monkeys.
McKearney JW
Neuropharmacology; 1989 Aug; 28(8):817-21. PubMed ID: 2779752
[TBL] [Abstract][Full Text] [Related]
22. Hyperthermia induced by m-trifluoromethylphenylpiperazine (TFMPP) or m-chlorophenylpiperazine (m-CPP) in heat-adapted rats.
Kłodzińska A; Chojnacka-Wójcik E
Psychopharmacology (Berl); 1992; 109(4):466-72. PubMed ID: 1365864
[TBL] [Abstract][Full Text] [Related]
23. Do functional relationships exist between 5-HT1A and 5-HT2 receptors?
Darmani NA; Martin BR; Pandey U; Glennon RA
Pharmacol Biochem Behav; 1990 Aug; 36(4):901-6. PubMed ID: 2145593
[TBL] [Abstract][Full Text] [Related]
24. Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in learning.
Meneses A; Hong E
Behav Brain Res; 1997 Aug; 87(1):105-10. PubMed ID: 9331478
[TBL] [Abstract][Full Text] [Related]
25. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
Aulakh CS; Hill JL; Murphy DL
J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
[TBL] [Abstract][Full Text] [Related]
26. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
Misane I; Ogren SO
Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
[TBL] [Abstract][Full Text] [Related]
27. Role of 5-hydroxytryptamine receptor subtypes in the 1-[3-(trifluoromethyl)phenyl] piperazine-induced increase in threshold for maximal electroconvulsions in mice.
Przegaliński E; Baran L; Siwanowicz J
Epilepsia; 1994; 35(4):889-94. PubMed ID: 8082639
[TBL] [Abstract][Full Text] [Related]
28. Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors.
Conn PJ; Sanders-Bush E
J Pharmacol Exp Ther; 1987 Aug; 242(2):552-7. PubMed ID: 3039120
[TBL] [Abstract][Full Text] [Related]
29. 2-(2-Aminoethyl)-quinoline (D-1997): a novel agonist at 5-hydroxytryptamine1-like receptors in the canine basilar artery.
Terrón JA; López-Muñoz FJ; Hong E; Villalón CM
Arch Int Pharmacodyn Ther; 1994; 327(1):56-68. PubMed ID: 7944828
[TBL] [Abstract][Full Text] [Related]
30. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.
Fiorella D; Helsley S; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 Dec; 122(3):237-43. PubMed ID: 8748393
[TBL] [Abstract][Full Text] [Related]
31. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
32. Decreased hypothalamic epinephrine concentration by quipazine and other serotonin agonists in rats.
Hemrick-Luecke SK; Fuller RW
Biochem Pharmacol; 1995 Jan; 49(3):323-7. PubMed ID: 7857319
[TBL] [Abstract][Full Text] [Related]
33. Autoregulatory properties of dorsal raphe 5-HT neurons: possible role of electrotonic coupling and 5-HT1D receptors in the rat brain.
Piñeyro G; de Montigny C; Weiss M; Blier P
Synapse; 1996 Jan; 22(1):54-62. PubMed ID: 8822478
[TBL] [Abstract][Full Text] [Related]
34. Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP).
Kłodzińska A; Jaros T; Chojnacka-Wójcik E; Maj J
J Neural Transm Park Dis Dement Sect; 1989; 1(3):207-18. PubMed ID: 2775468
[TBL] [Abstract][Full Text] [Related]
35. Improvement of the isolation-induced social behavioural deficit involves activation of the 5-HT1B receptors.
Frances H; Lienard C; Fermanian J
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):91-102. PubMed ID: 2300682
[TBL] [Abstract][Full Text] [Related]
36. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
[TBL] [Abstract][Full Text] [Related]
37. Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors.
Callahan PM; Cunningham KA
J Pharmacol Exp Ther; 1995 Sep; 274(3):1414-24. PubMed ID: 7562516
[TBL] [Abstract][Full Text] [Related]
38. Induction of purposeless chewing behaviour in rats by 5-HT agonist drugs.
Stewart BR; Jenner P; Marsden CD
Eur J Pharmacol; 1989 Mar; 162(1):101-7. PubMed ID: 2524394
[TBL] [Abstract][Full Text] [Related]
39. Receptor subtypes mediating facilitation by serotonin of excitability of spinal motoneurons.
Jackson DA; White SR
Neuropharmacology; 1990 Sep; 29(9):787-97. PubMed ID: 2149874
[TBL] [Abstract][Full Text] [Related]
40. Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
Sanders-Bush E; Breeding M
J Pharmacol Exp Ther; 1990 Mar; 252(3):984-8. PubMed ID: 2319481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
